Core Viewpoint - Johnson & Johnson is positioned as a resilient and growth-oriented company, capable of weathering market volatility and benefiting from its strong pipeline and consistent dividend payments [1]. Group 1: Resilience - Johnson & Johnson has a long history of resilience, having thrived through various economic challenges since its founding in 1886, generating nearly 14 billion in profits last year [2]. - The company's share price has increased by approximately 6% this year, contrasting with a 9% decline in the S&P 500, showcasing its ability to maintain growth despite market conditions [3]. Group 2: Growth Potential - In Q1 2025, Johnson & Johnson's sales grew by 2.4% year over year, with operational growth at 4.2%, indicating a stable growth trajectory [4]. - The company anticipates accelerated growth in the latter half of the decade, supported by six regulatory approvals for drugs this year and expectations for nine additional approvals in 2025 [4][5]. Group 3: Tariff Resistance - Johnson & Johnson is expected to be less affected by tariffs compared to other companies, with a focus on maintaining supply chain stability and investing over $55 billion in U.S. manufacturing and R&D over the next four years [6]. Group 4: Dividend Strength - The company has increased its dividend for 63 consecutive years, with a forward dividend yield of 3.37%, reinforcing its status as a Dividend King and providing investors with returns during turbulent market periods [8].
4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market